Publicado 05/02/2019 13:20
- Comunicado -

Merck and GSK Announce Global Alliance to Jointly Develop and Commercialize M7824, a Novel Immunotherapy with Potential

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.

Your Contacts Media Relations Friederike.Segeberg@merckgroup.com Phone: +49-6151-72-6328 Investor Relations investor.relations@merckgroup.com Phone: +49-6151-72-3321

Logo: https://mma.prnewswire.com/media/765882/... [https://mma.prnewswire.com/media/765882/...]

Web site: http://www.merckgroup.com/

Contenido patrocinado